alpha-Glucosidase/NLRP3-IN-1 (Compound 8) acts as a dual inhibitor targeting both alpha-glucosidase and NLRP3. It features an IC50 value of 6.6 µM for alpha-glucosidase and inhibits NLRP3 across multiple cell lines at a concentration of 100 µM. This compound demonstrates neuroprotective and antidiabetic properties, making it suitable for related research.